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BACKGROUND 
The emergency contraceptive pill (ECP) is an 
effective postcoital contraceptive method, 
providing women with the opportunity to avoid 
unwanted pregnancy after sex in which a 
contraceptive either was not used or failed. In 
India, where unintended pregnancy rates are high, 
ECP was included in the National Family Planning 
Program in 2002 and made an over-the-counter 
(OTC) drug in 2005. Since ECP has been made 
available OTC, concerns have been raised that the 
easy availability and lack of knowledge regarding 
correct use of ECP—even among providers—may 
lead to its misuse, its repeat use within the same 
menstrual cycle, replacement of precoital family 
planning methods, and an increase in promiscuity. 
Although no serious harmful effects have been 
associated with repeat use of ECP, the method 
should not be used repeatedly because it is less 
reliable than other modern methods of birth 
spacing. 
 
OBJECTIVE 
The present study explores providers’ knowledge 
of how ECP works and its safety and 
effectiveness, their perceptions of the frequency 
of repeat use, their provision of ECP, and their 
attitudes toward women who seek it. 
METHODOLOGY  
A quantitative survey of 315 providers—199 
pharmacists, 83 OB/GYN doctors, 33 
paramedics—was conducted in four cities of Uttar 
Pradesh (Agra, Aligarh, Kanpur, and Lucknow) and 
in Delhi. The sampling frame for Uttar Pradesh was 
drawn from a list of doctors and pharmacies 
provided by the Urban Health Initiative. The 
sampling frame for Delhi was limited to 
pharmacies and was created by dividing the city 
into four sections and randomly sampling 
pharmacies from each section. (A qualitative study 
of 19 key opinion leaders was also conducted, and 
those findings are presented elsewhere.) 
 
FINDINGS 
 Most of the doctors (96 percent) knew the 
mechanism by which ECP prevents pregnancy. 
In contrast, 40 percent of paramedics and 61 
percent of pharmacists lacked such knowledge. 
 Eighty-six percent of providers believed that 
ECP is safe, and 82 percent thought it was very 
effective in preventing pregnancy. 
 Forty-three percent of doctors, 24 percent of 
paramedics, and only 11 percent of 
pharmacists had ever received training in ECP. 
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Very few (13 percent) had received literature on ECP, 
provided mainly by pharmaceutical firms. 
 Ninety percent of doctors, 72 percent of paramedics, 
and 55 percent of pharmacists knew that ECP cannot 
induce abortion. 
 Many doctors and paramedics mistakenly believed 
that ECP cannot be used by women with heart 
problems or who are breastfeeding. 
 Doctors expressed greater reservations than did 
other providers about ECP use, distribution as an OTC 
drug, and provision by paramedics.  
 Male providers were more than three times as likely 
as female providers (OR=3.5, p<0.01) to support 
availability of ECP as an OTC drug. 
 Logistic regression analysis showed that providers 
who are male, young (aged 15–35 years), and trained 
were two times as likely to support ECP provision, 
compared with their female, older (35+), and 
untrained counterparts, respectively. 
 The majority of providers (72 percent of pharmacists, 
57 percent doctors) believed that many women are 
using ECP repeatedly, but not necessarily in the same 
cycle.   
 
 
TABLE 1    Percentage of providers expressing various 
attitudes toward ECP (N=315) 
Attitude 
Doctors 
(n = 83) 
Paramedics 
(n = 33) 
Pharmacists 
(n = 199) 
Disapproved of OTC 
availability of ECP 67 61 34 
Believed ECP use 
among unmarried girls  
is appropriate 29 33 49 
Favored minimum-age 
restriction for ECP use 84 94 74 
Believed ECP use will 
promote promiscuity 45 59 46 
Believed people may 
use ECP as regular 
contraceptive 39 30 31 
Approved provision of  
ECP as  prophylactic 48 58 58 
 
 
POLICY IMPLICATIONS 
Many of the findings of this study are encouraging. 
Most providers believed that ECP is an effective and 
safe method to prevent pregnancy and that it cannot 
induce abortion, and half supported the OTC 
provision of ECP. Although most providers (88–92 
percent) viewed married women as the most 
appropriate users of ECP, 42 percent approved its 
use among unmarried girls. Nevertheless, the study 
revealed many biases and gaps in knowledge. The 
majority of doctors oppose OTC availability of ECP 
and its provision by those lacking medical training. 
Few providers reported receiving any orientation or 
literature regarding ECP. The study also found that in 
urban areas, particularly large cities like Delhi, ECP 
use is common, and that many users are young and 
unmarried. Repeated use of ECP is confirmed by 
pharmacists who have returning customers. These 
findings suggest that the following steps should be 
taken: 
1. An educational campaign is needed to overcome 
the negative attitudes toward ECP among doctors 
and other stakeholders.  
2. Advertisements for condoms and the pill should 
mention ECP as a backup method.  
3. Companies that advertise their ECP brand on TV 
and in newspapers should state clearly that ECP is 
not intended for use as a primary contraceptive 
method. Similarly, ECP packaging should state 
that it is only for emergency use. 
4. Medical representatives, wholesalers, and 
pharmacists’ associations should educate 
pharmacists about the correct use of ECP and, 
when possible, provide a brochure explaining how 
ECP works and its correct use.  
5. A formative study should be undertaken to assess 
the feasibility of using pharmacies—the main 
direct supply point for ECP—as a source of 
information for ECP users. 
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